Explanation of Shenzhen Microchip Biotechnology Co., Ltd. on the fund-raising investment in the field of scientific and technological innovation
Notice on not being subject to regulatory measures or penalties by securities regulators and stock exchanges in the last five years
Announcement of Resolutions of the 8th Meeting of the Third Board of Directors
Resolutions of the 1st Meeting of the 3rd Special Meeting of Independent Directors of the Board of Directors in 2024
Announcement of Resolutions of the Sixth Meeting of the Third Board of Supervisors
Special report on the use of funds raised last time
Verification report of the previous special report on the use of funds raised
Investor Relations Activity Schedule November 13, 2024
Notice on voluntary disclosure of approval for clinical trials of drugs obtained by Theoroni capsules for first-line treatment of widespread small-cell lung cancer
Investor Relations Activity Record Form October 31, 2024
Microchip Biotech: Announcement of Resolutions of the 7th Meeting of the 3rd Board of Directors
Microchip Biotech: Announcement on Early Termination of Promotion Cooperation with Haizheng Pharmaceutical
Microchip Biotech: Announcement of Resolutions of the Fifth Meeting of the Third Board of Supervisors
Microchip Biotech: Announcement on holding the results briefing for the third quarter of 2024
Announcement of Resolutions of the Fifth Meeting of the Third Board of Supervisors
Announcement on holding the results briefing for the third quarter of 2024
Announcement of Resolutions of the 7th Meeting of the Third Board of Directors
Microchip Biotech: Voluntary Disclosure Notice on Acceptance of Clinical Trial Application for CS231295 Tablets
Investor Relations Activity Record Form September 10, 2024
SDIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shenzhen Microchip Biotechnology Co., Ltd.
No Data
No Data